Adalimumab for maintenance of clinical response and remission in patients with Crohn&apos;s disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P et al. Gastroenterology 2007;132:52-65.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Pediatr Gastroenterol Nutr

Title: Journal of pediatric gastroenterology and nutrition

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1536-4801

ISSN (Print): 0277-2116

Publication date (Electronic): Feb 2008

Volume: 46

Issue: 2

Affiliations

[1 ] Department of Paediatric Gastroenterology, Booth Hall Children's Hospital, Manchester, UK.

Article

Publisher Item ID: 00005176-200802000-00021

DOI: 10.1097/MPG.0b013e318156e139

PubMed ID: 18223389

SO-VID: e3404c46-aae0-48b3-bcf1-d6d465ceb7dc

History

Data availability:

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P et al. Gastroenterology 2007;132:52-65.

Read this article at

Related collections

Karger: Gastroenterology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 1,106

Cited by 2